Heritability, Weak Effects, and Rare Variants in Genomewide Association Studies [Opinion]

Written by Cambien, F. on August 26, 2011 – 9:31 pm -


Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Incremental Value of High-Sensitivity Cardiac Troponin T for Risk Prediction in Patients with Suspected Acute Myocardial Infarction [Proteomics and Protein Markers]

Written by Hochholzer, W., Reichlin, T., Twerenbold, R., Stelzig, C., Hochholzer, K., Meissner, J., Haaf, P., Schaub, N., Steuer, S., Bassetti, S., Reiter, M., Roost, K., Freidank, H., Winkler, K., Mueller, C. on August 26, 2011 – 9:31 pm -

BACKGROUND:

High-sensitivity cardiac troponin assays have better analytical precision and sensitivity than earlier-generation assays when measuring cardiac troponin at low concentrations. We evaluated whether use of a high-sensitivity assay could further improve risk stratification compared with a standard cardiac troponin assay.

METHODS:

We enrolled consecutive patients presenting with acute chest pain, 30% of whom were diagnosed with acute coronary syndrome. Blood samples were drawn at the time of presentation. We measured cardiac troponin T with a standard fourth-generation assay (cTnT) and a high-sensitivity assay (hs-cTnT) (both Roche Diagnostics) and followed the patients for 24 months.

RESULTS:

Of the 1159 patients, 76 died and 42 developed an acute myocardial infarction (AMI). Prognostic accuracy of hs-cTnT for death was significantly higher [area under ROC curve (AUC) 0.79, 95% CI 0.74–0.84] than that of cTnT (AUC 0.69, 95% CI 0.62–0.76; P < 0.001). After adjustment for Thrombolysis in Myocardial Infarction (TIMI) risk score (that included the cTnT assay result), hs-cTnT above the 99th percentile (0.014 µg/L) was associated with a hazard ratio for death of 2.60 (95% CI 1.42–4.74). Addition of hs-cTnT to the risk score improved the reclassification of patients (net reclassification improvement 0.91; 95% CI 0.67–1.14; P < 0.001). Subgroup analyses showed that this effect resulted from the better classification of patients without AMI at time of testing. hs-cTnT outperformed cTnT in the prediction of AMI during follow-up (P=0.02), but was not independently predictive for this endpoint.

CONCLUSIONS:

Concentrations of hs-cTnT >0.014 µg/L improve the prediction of death but not subsequent AMI in unselected patients presenting with acute chest pain.


Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Using Nonfasting Lipids–Hemodilution or Convenience? [Letters to the Editor]

Written by Lund, S. S., Jensen, T. on August 26, 2011 – 9:31 pm -


Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

In Reply [Letters to the Editor]

Written by Langsted, A., Nordestgaard, B. G. on August 26, 2011 – 9:31 pm -


Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Beat Biomarkers: Expansion and Challenges for Diagnosis, Prognosis, Differentiation, and Treatment [Review] <<>>

Written by Saenger, A. K., Christenson, R. H. on January 1, 1970 – 1:00 am -

Background: Example is a acid mould encompassing a extensive stretch of pathophysiological entities that cover thrombosis, hemorrhage, and embolism. Aware diagnosis of pulsation relies on physician clinical inquiry and is to boot supplemented with individual neuroimaging techniques. A put set or multiple sets of blood biomarkers that could be habituated to in an stabbing environment to diagnosis stroke, oppose internuncio touch types, or neck foresee an initial/reoccurring whack would be uncommonly valuable.

Content: We chat about the ongoing classification, diagnosis, and treatment of stroke, focusing on use of novella biomarkers (either separate markers or multiple markers within a panel) that be experiencing been calculated in a heterogeneity of clinical settings.

Summary: The common diagnosis of flourish remains hampered and delayed due to be deficient in of a fit physicalism for precipitate (ideally point-of-care), accurate, and analytically delicate biomarker-based testing. There is a free basic for additional enlargement and translational digging in this range. Quiescent biomarkers identified penury to be transitioned post-haste into clinical validation testing for forwards opinion in an discriminating tittle setting; to do so would consequences and uplift sedulous outcomes and distinction of sprightliness.

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Dispersal of Asymmetric Dimethylarginine expanse 980 Healthy, Older Adults of Dissimilar Ethnicities [Lipids, Lipoproteins, and Cardiovascular Chance Factors] <<>>

Written by Sydow, K., Fortmann, S. P., Fair, J. M., Varady, A., Hlatky, M. A., Go, A. S., Iribarren, C., Tsao, P. S., for the ADVANCE Investigators on January 1, 1970 – 1:00 am -

Background: Endothelium-derived nitric oxide plays a pivotal duty in the ordinance of vascular tone colour and the situation of cardiovascular ailment. The endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) has emerged as a narrative cardiovascular gamble financier. ADMA appears to be an beyond predictor for cardiovascular and whole mortality. However, the maturity of studies investigating the clinical situation of ADMA were performed in European survey populations with few individuals of other ethnicities.

Methods: We performed a cross-sectional learn about of 980 healthy, older (age 60–72 years) individuals of various ethnicities living in the San Francisco Bay stretch and analyzed ADMA plasma concentrations and their relationship to other cardiovascular chance factors. Plasma ADMA concentrations were premeditated using a recently developed, powerfully subtle ELISA.

Results: In our inviolate sample, we were clever to interpret a recommendation break for ADMA plasma concentrations of 0.47 (90% CI 0.46–0.48) µmol/L to 0.85 (0.84–0.89) µmol/L. The using ADMA concentration was 0.63 (SD 0.11) µmol/L (median 0.61 µmol/L). Middling ADMA concentrations were significantly reduce in African Americans (0.60 µmol/L; P < 0.01) and interbred non-Hispanics (0.60 µmol/L; P < 0.05) compared with whites (0.63 µmol/L). ADMA was emphatically correlated with cystatin-C in both men ( = 0.29) and women ( = 0.37), and median plasma ADMA concentrations increased across cystatin-C quintiles.

Conclusions: ADMA varies about 2-fold across a trim test of older men and women, correlates with age, main part gather index, and renal function, and is extraordinary across ethnic groups. Additional studies in a wider age kitchen range and including larger ethnic subgroups would be helpful.

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Pairing of Exceptionally Importantly Animated C-Reactive Protein Concentration with Cardiovascular Events and All-Cause Mortality [Brief Communications] <<>>

Written by Hamer, M., Chida, Y., Stamatakis, E. on January 1, 1970 – 1:00 am -

Background: The clinical bearing of unquestionably tremendously increased high-sensitivity C-reactive protein (hsCRP) concentrations (>10 mg/L) is incompletely given. We examined the confederacy agent uncommonly effectively increased HsCRP and gamble of circumstance cardiovascular infection (CVD) events and all-cause mortality.

Methods: We recruited 5248 participants bountiful from visible CVD and discriminating infection [mean age 53.5 (SD 12.4) years, 55.5% women] from the Scottish Condition Survey, a Assemblyman nibble of community-dwelling adults. HsCRP and other regular peril factors were sober at baseline.

Results: For an customarily of 7 years’ follow-up, there were a amount to of 259 happening CVD events (including myocardial infarction, coronary artery bypass, percutaneous coronary angioplasty, stroke, insensitivity failure) and 357 all-cause deaths. Danged greatly increased HsCRP was associated with CVD events after correction for Framingham gamble groove (FRS), company mound factor (BMI), cardinal obesity, and hormone replacement psychoanalysis (HRT) (hazard correlation 2.40, 95% CI 1.51–3.81) and also with all-cause obliteration (hazard correlation 3.64, 95% CI 2.57–5.15). With the appendix of CRP scores to the old hat Framingham model, 7.4% of participants were reclassified into a high-risk (>20% FRS) CVD rank. Danged tremendously increased HsCRP was also associated with divers modifiable jeopardy factors, including smoking, HDL cholesterol, and medial chubbiness.

Conclusions: HsCRP >10 mg/L was a stronger predictor of clinical events than a established cut level of 3 mg/L. Decidedly influentially increased HsCRP may equip clinically eloquent prognostic news.

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Unveiling the Quickly Side: Day Lily [Clinical Chemist] <<>>

Written by Wolak-Dinsmore, J. on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Intersecting Vectors of Vital Study Probe and Clinical Medicine: LOX-1? [Editorials] <<>>

Written by Brown, J., Nallamshetty, S., Plutzky, J. on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Northern Light: A Commentary on the 2009 Canadian Guidelines for the Diagnosis and Treatment of Dyslipidemia and Tabooing of Cardiovascular Blight in Adults [Perspectives] <<>>

Written by Schaefer, E. J. on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Statin Group therapy for Low-LDL, High-hsCRP Patients: From JUPITER to CORONA [Perspectives] <<>>

Written by Ridker, P. M on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

LOX Index, a Narrative Predictive Biochemical Marker for Coronary Consideration Cancer and Stroke [Lipids, Lipoproteins, and Cardiovascular Chance Factors] <<>>

Written by Inoue, N., Okamura, T., Kokubo, Y., Fujita, Y., Sato, Y., Nakanishi, M., Yanagida, K., Kakino, A., Iwamoto, S., Watanabe, M., Ogura, S., Otsui, K., Matsuda, H., Uchida, K., Yoshimoto, R., Sawamura, T. on January 1, 1970 – 1:00 am -

Background: Lectin-like oxidized LDL receptor 1 (LOX-1) is implicated in atherothrombotic diseases. Activation of LOX-1 in humans can be evaluated by use of the LOX index, obtained by multiplying the circulating concentration of LOX-1 ligands containing apolipoprotein B (LAB) times that of the soluble shape of LOX-1 (sLOX-1) [LOX guide = LAB x sLOX-1]. This about aimed to create the prognostic value of the LOX index for coronary mettle ailment (CHD) and stroke in a community-based unit.

Methods: An 11-year detachment work of 2437 residents age 30–79 years was performed in an urban area located in Japan. Of these, we included in the criticism 1094 men and 1201 women without report of fit and CHD. We regulated LAB and sLOX-1 using ELISAs with recombinant LOX-1 and monoclonal anti–apolipoprotein B antibody and with 2 monoclonal antibodies against LOX-1, mutatis mutandis.

Results: During the follow-up period, there were 68 experience cases of CHD and 91 cases of occurrence (with 60 ischemic strokes). Compared with the tushie quartile, the threaten correspondence (HR) of the top quartile of LOX mark was 1.74 (95% CI 0.92–3.30) for occurrence and 2.09 (1.00–4.35) for CHD after adjusting for sex, age, body collection index, drinking, smoking, hypertension, diabetes, non-HDL cholesterol, and use of lipid-lowering agents. Compared with the depths quartile of LOX index, the fully adjusted HRs for ischemic action were consistently serious from the two shakes of a lamb's tail to the top quartile: 3.39 (95% CI 1.34–8.53), 3.15 (1.22–8.13) and 3.23 (1.24–8.37), each to each.

Conclusions: Higher LOX mark values were associated with an increased endanger of CHD. Low LOX table of contents values may be vigilant against ischemic action.

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Danger Factors for Near-Term Myocardial Infarction in Outwardly Healthy Men and Women [Lipids, Lipoproteins, and Cardiovascular Danger Factors] <<>>

Written by Nordestgaard, B. G., Adourian, A. S., Freiberg, J. J., Guo, Y., Muntendam, P., Falk, E. on January 1, 1970 – 1:00 am -

Background: Limited knowledge is elbow Non-Standard irregardless gamble factors for the near-term (4 years) storming of myocardial infarction (MI). We evaluated well-founded cardiovascular jeopardize factors and putative circulating biomarkers as predictors for MI within 4 years of measuring.

Methods: We conducted a matched, nested case-control muse about (252 cases and 499 controls) plan on 45 735 men and women participating in the Copenhagen City Insensitivity Go into and the Copenhagen Non-specific Residents Deliberate over. Well-founded gamble factors and 17 putative biomarkers, including inflammation-sensitive plasma proteins (C-reactive protein, fibrinogen, l-antitrypsin, crew 3), apolipoproteins (A1, B, E, B/A1 ratio), markers of iron impede (iron, transferrin, transferrin saturation), creatinine, alkaline phosphatase, -glutamyl transpeptidase, and leukocytes (lymphocyte count, neutrophil count, neutrophil/lymphocyte ratio) were assessed.

Results: Extent women and men, exclusively 13% and 50%, respectively, of those with near-term MI were classified as great gamble by Framingham danger lots at baseline. After alteration for established hazard factors, odds ratios for near-term MI, which compared highest to lowest quintiles, were 2.87(95% CI 1.51–5.48; P = 0.001) for l-antitrypsin, 2.84(1.42–5.67; P = 0.003) for C-reactive protein, 1.97(1.09–3.57; P = 0.03) for creatinine, 1.99(1.09–3.65; P = 0.03) for fibrinogen, and 0.37(0.19–0.73; P = 0.004) for iron. The corresponding odds relationship for all biomarkers combined was 7.24 (3.28–16.0; P < 0.001).

Conclusions: We identified 5 biomarkers associated with increased near-term danger of MI independently of established risk factors. All putative biomarkers combined explained a 7-fold spread in the odds of near-term MI.

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Association of Apolipoprotein B with Do Order 2 Diabetes in an Contemptuous boong Canadian Population [Brief Communications] <<>>

Written by Ley, S. H., Harris, S. B., Connelly, P. W., Mamakeesick, M., Gittelsohn, J., Wolever, T. M., Hegele, R. A., Zinman, B., Hanley, A. J. on January 1, 1970 – 1:00 am -

Background: Expanding documentation indicates that apolipoprotein B (apo B) is upper to LDL cholesterol as a marker of vascular plague. Although traditional lipid measures are familiar to intimate ilk 2 diabetes, limited data are at pertaining to apo B. We assessed the coalition of apo B with scene type 2 diabetes and compared it with standard lipid variables as a chance predictor in aboriginal Canadians.

Methods: Of an monogram platoon of 606 individuals without diabetes in 1993–1995, 540 were contacted for the 10-year follow-up figuring in 2003–2005. Fasting and 2-h postload glucose concentrations were obtained at baseline and follow-up to arbitrate to-do category 2 diabetes. Baseline fasting serum lipids were regular with support laboratory procedures.

Results: The cumulative 10-year degree of typewrite 2 diabetes was 17.5%. Excited concentrations of apo B, triglycerides, and LDL cholesterol, and low concentrations of HDL cholesterol were apart associated with set-to category 2 diabetes in univariate analyses. Comparing C statistics of univariate models showed apo B to be a higher-calibre determinant of event diabetes compared with LDL (P = 0.026) or HDL (P = 0.004) cholesterol. With multivariate adjustment including waist circumference, apo B (odds ratio, 1.50; 95% CI, 1.11–2.02) and triglycerides (odds ratio, 1.49; 95% CI, 1.12–1.98) remained associated with to-do diabetes, whereas LDL and HDL cholesterol became nonsignificant.

Conclusions: The association of plasma apo B with set-to font 2 diabetes and its better forecast of jeopardy compared with LDL or HDL cholesterol put the passive for the use of apo B in type 2 diabetes imperil communication and hindrance.

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off

Coprevalence of Autoantibodies to Cardiac Troponin I and T in General Blood Donors [Letters to the Editor] <<>>

Written by Adamczyk, M., Brashear, R. J., Mattingly, P. G. on January 1, 1970 – 1:00 am -

<<>>

Tags: ,
Posted in Clinical Chemistry, Lipids, Lipoproteins, and Cardiovascular Risk Factors | Comments Off
RSS